Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371 · see citing works

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329 · see citing works

Synchronization

PIKOVSKY, A. S., Rosenblum, M., & Kurths, J. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511755743 · Cited by 8,250 · see citing works

Synchronization a universal concept in nonlinear sciences

PIKOVSKY, A. S., Rosenblum, M. G., & Kurths, J. (2001) · Cited by 5,640 · see citing works

From Kuramoto to Crawford: exploring the onset of synchronization in populations of coupled oscillators

Strogatz, S. H. (2000) · Physica D Nonlinear Phenomena · doi:10.1016/s0167-2789(00)00094-4 · Cited by 3,094 · see citing works

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606 · see citing works

Electric Fields of the Brain

Nunez, P. L., & Srinivasan, R. (2006) · doi:10.1093/acprof:oso/9780195050387.001.0001 · Cited by 2,531 · see citing works

Cortical inhibitory neurons and schizophrenia

Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · see citing works

Electric Fields of the Brain: The Neurophysics of EEG

Nunez, P. L., & Harth, E. M. (1982) · Physics Today · doi:10.1063/1.2915137 · Cited by 2,257 · see citing works

Neural synchrony in brain disorders: Relevance for cognitive dysfunctions and pathophysiology

Uhlhaas, P. J., & Singer, W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.020 · Cited by 2,194 · see citing works

Abnormal neural oscillations and synchrony in schizophrenia

Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120 · see citing works

Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks

Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070 · see citing works

Diagnostic Interview for Genetic Studies

Nürnberger, J. I. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110009002 · Cited by 2,066 · see citing works

The neuropathology of schizophrenia

Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677 · see citing works

Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia

Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636 · see citing works

EEG coherency

Nunez, P. L., Srinivasan, R., Westdorp, A. F., Wijesinghe, R. S., Tucker, D. M., Silberstein, R. B., & Cadusch, P. J. (1997) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/s0013-4694(97)00066-7 · Cited by 1,230 · see citing works

Scalp electrode impedance, infection risk, and EEG data quality

Ferrée, T. C., Luu, P., Russell, G. S., & Tucker, D. M. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00533-2 · Cited by 1,008 · see citing works

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

Thompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., Toga, A. W., & Rapoport, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201243998 · Cited by 812 · see citing works

Symptoms of Schizophrenia

Andreasen, N. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170015003 · Cited by 736 · see citing works

Principal components analysis of Laplacian waveforms as a generic method for identifying ERP generator patterns: I. Evaluation with auditory oddball tasks

Jürgen Kayser, A., & Tenke, C. E. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.08.034 · Cited by 638 · see citing works

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase

Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works

Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers

Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., & Javitt, D. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1139 · Cited by 583 · see citing works

GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia

González‐Burgos, G., & Lewis, D. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn070 · Cited by 568 · see citing works

Thalamic Mechanisms of EEG Alpha Rhythms and Their Pathological Implications

Hughes, S. W., & Crunelli, V. (2005) · The Neuroscientist · doi:10.1177/1073858405277450 · Cited by 565 · see citing works

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works

Schizophrenic syndromes, cognitive performance and neurological dysfunction

Liddle, P. F. (1987) · Psychological Medicine · doi:10.1017/s0033291700012976 · Cited by 552 · see citing works

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo

Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works

EEG and MEG coherence: Measures of functional connectivity at distinct spatial scales of neocortical dynamics

Srinivasan, R., Winter, W., Ding, J., & Nunez, P. L. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.06.026 · Cited by 538 · see citing works

Dysfunctional Long-Range Coordination of Neural Activity during Gestalt Perception in Schizophrenia

Uhlhaas, P. J., Linden, D. E. J., Singer, W., Haenschel, C., Lindner, M., Maurer, K., & Rodríguez, E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2002-06.2006 · Cited by 432 · see citing works

Mismatch negativity: An index of a preattentive processing deficit in schizophrenia

Shelley, A. M., Ward, P. B., Catts, S. V., Michie, P. T., Andrews, S., & McConaghy, N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90126-7 · Cited by 411 · see citing works

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 397 · see citing works

Redox dysregulation, neurodevelopment, and schizophrenia

Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works

Gamma Oscillations in the Hippocampus

Colgin, L. L., & Moser, E. I. (2010) · Physiology · doi:10.1152/physiol.00021.2010 · Cited by 376 · see citing works

Alpha rhythms as physiological and abnormal phenomena

Niedermeyer, E. (1997) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(97)00754-x · Cited by 376 · see citing works

Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371 · see citing works

Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro

Traub, R. D., Bibbig, A., LeBeau, F. E. N., Buhl, E. H., & Whittington, M. A. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144303 · Cited by 358 · see citing works

The status of spectral EEG abnormality as a diagnostic test for schizophrenia

Boutros, N. N., Arfken, C. L., Galderisi, S., Warrick, J. I., Pratt, G., & Iacono, W. G. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.020 · Cited by 324 · see citing works

Altered glutathione redox state in schizophrenia.

Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works

Introduction to Modern Nonparametric Statistics

Higgins, J. J. (2003) · Cited by 313 · see citing works

Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence

Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309 · see citing works

Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version

Preisig, M., Fenton, B. T., Matthey, M., Berney, A., & Ferrero, F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050084 · Cited by 307 · see citing works

Introduction to Modern Nonparametric Statistics

Fotopoulos, S. (2004) · Technometrics · doi:10.1198/tech.2004.s229 · Cited by 301 · see citing works

Are There More Than Two Syndromes in Schizophrenia?

Peralta, V., de León, J., & Cuesta, M. J. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.3.335 · Cited by 301 · see citing works

Alterations of cortical GABA neurons and network oscillations in schizophrenia

Gonzalez-Burgos, G., Hashimoto, T., & Lewis, D. A. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0124-8 · Cited by 260 · see citing works

Multiple origins of the cortical gamma rhythm

Whittington, M. A., Cunningham, M. O., LeBeau, F. E. N., Racca, C., & Traub, R. D. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20814 · Cited by 253 · see citing works

Impairment of early cortical processing in schizophrenia: An event-related potential confirmation study

Javitt, D. C., Doneshka, P., Zylberman, I., Ritter, W., & Vaughan, H. G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90005-x · Cited by 236 · see citing works

Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene

Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234 · see citing works

Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review

Näätänen, R., & Kähkönen, S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009322 · Cited by 233 · see citing works

Redox Dysregulation Affects the Ventral But Not Dorsal Hippocampus: Impairment of Parvalbumin Neurons, Gamma Oscillations, and Related Behaviors

Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202 · see citing works

Clinical and biological concomitants of resting state EEG power abnormalities in schizophrenia

Sponheim, S. R., Clementz, B. A., Iacono, W. G., & Beiser, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00907-0 · Cited by 191 · see citing works

Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia

Basso, M. R., Nasrallah, H. A., Olson, S. C., & Bornstein, R. A. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00023-1 · Cited by 190 · see citing works

Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia

Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173 · see citing works

Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naıve patients with schizophrenia: preliminary results

Koenig, T. W., Lehmann, D., Saito, N. H., Kuginuki, T., Kinoshita, T., & Koukkou, M. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00154-7 · Cited by 169 · see citing works

Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?

Behrens, M. M., & B, T. J. S. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.002 · Cited by 160 · see citing works

Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia

Grima, G. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00405-x · Cited by 140 · see citing works

Assessment of EEG synchronization based on state-space analysis

Carmeli, C., Knyazeva, M. G., Innocenti, G. M., & Feo, O. D. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.11.049 · Cited by 140 · see citing works

Constrained least square design of FIR filters without specified transition bands

Selesnick, I., Lang, M., & Burrus, C. S. (1996) · IEEE Transactions on Signal Processing · doi:10.1109/78.533710 · Cited by 126 · see citing works

Neural circuits underlying the generation of theta oscillations

Pignatelli, M., Beyeler, A., & Leinekugel, X. (2011) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2011.09.007 · Cited by 124 · see citing works

Topography of EEG multivariate phase synchronization in early Alzheimer's disease

Knyazeva, M. G., Jalili, M., Brioschi, A. M., Bourquin, I., Fornari, E., Hasler, M., Meuli, R. A., Maeder, P. P., & Ghika, J. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.019 · Cited by 118 · see citing works

Magnetoencephalographic gamma power reduction in patients with schizophrenia during resting condition

Rutter, L. A., Carver, F. W., Holroyd, T., Nadar, S. R., Mitchell-Francis, J., Apud, J. A., Weinberger, D. R., & Coppola, R. (2009) · Human Brain Mapping · doi:10.1002/hbm.20746 · Cited by 116 · see citing works

The Human Cortical White Matter

Braitenberg, V., & Sch√ºz, A. (2002) · Conceptual advances in brain research · doi:10.1201/9780203299296.ch16 · Cited by 112 · see citing works

Cortical Areas

Schüz, A. (2002) · CRC Press eBooks · doi:10.1201/9780203299296 · Cited by 111 · see citing works

Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia

Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96 · see citing works

Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: Relevance to schizophrenia

Cabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 83 · see citing works

Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia

Matsuzawa, D., & Hashimoto, K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3453 · Cited by 79 · see citing works

Increased absolute magnitude of gamma synchrony in first-episode psychosis

Flynn, G., Alexander, D. M., Harris, A. W. F., Whitford, T. J., Wong, W. K. M., Galletly, C. A., Silverstein, S. M., Gordon, E., & Williams, L. M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.029 · Cited by 71 · see citing works

Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia

Castagné, V., Rougemont, M., Cuénod, M., & Kim, Q. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.005 · Cited by 71 · see citing works

Dysconnection Topography in Schizophrenia Revealed with State-Space Analysis of EEG

Jalili, M., Lavoie, S., Deppen, P., Meuli, R. A., Kim, Q., Cuénod, M., Hasler, M., Feo, O. D., & Knyazeva, M. G. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001059 · Cited by 66 · see citing works

Are oscillatory brain responses generally reduced in schizophrenia during long sustained attentional processing?

Başar‐Eroğlu, C., Schmiedt‐Fehr, C., Mathes, B., Zimmermann, J., & Brand, A. (2008) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.07.004 · Cited by 53 · see citing works

An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development

Castagné, V., Cuénod, M., & Do, K. Q. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.012 · Cited by 50 · see citing works

Reaction time, symptom profiles and course of illness in schizophrenia

Ngan, E. T. C., & Liddle, P. F. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00027-x · Cited by 50 · see citing works

Exploring intermediate phenotypes with EEG: Working memory dysfunction in schizophrenia

Haenschel, C., & Linden, D. E. J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.045 · Cited by 47 · see citing works

Cortical Network Analysis in Patients Affected by Schizophrenia

Fallani, F. D. V., Maglione, A. G., Babiloni, F., Donatella Mattia, A., Laura Astolfi, A., Vecchiato, G., Rinaldis, A. D., Salinari, S., Pachou, E., & Micheloyannis, S. (2010) · Brain Topography · doi:10.1007/s10548-010-0133-2 · Cited by 46 · see citing works

Dissociative symptoms and interregional EEG cross-correlations in paranoid schizophrenia

Bob, P., Šusta, M., Gláslová, K., & Boutros, N. N. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.08.015 · Cited by 44 · see citing works

Abnormally high EEG alpha synchrony during working memory maintenance in twins discordant for schizophrenia

Bachman, P., Kim, J., Yee, C. M., Therman, S., Manninen, M., Lönnqvist, J. K., Kaprio, J. A., HUTTUNEN, M. O., Näätänen, R., & Cannon, T. D. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.006 · Cited by 42 · see citing works

New model of glutathione deficit during development: Effect on lipid peroxidation in the rat brain

Rougemont, M., Kim, Q., & Castagné, V. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10439 · Cited by 40 · see citing works

A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.

Steullet, P., Lavoie, S., Kraftsik, R., Guidi, R., Gysin, R., Cuenod, M., & Do, K. (2008) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2007.12.006 · Cited by 29 · see citing works

2.5 Redox Dysregulation in Schizophrenia: Genetic Susceptibility and Pathophysiological Mechanisms

Do, K., Cuenod, M., & Javitt, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_8 · Cited by 24 · see citing works

Assessing cooperative behavior in dynamical networks with applications to brain data

Carmeli, C. (2006) · reroDoc Digital Library · doi:10.5075/epfl-thesis-3651 · Cited by 11 · see citing works

The Human Cortical White Matter: Quantitative Aspects of Cortico-Cortical Long-Range Connectivity

Schüz, A., Braitenberg, V., Schüz, A., & Miller, R. (2002) · Max Planck Institute for Plasma Physics · Cited by 11 · see citing works

Binding under Conflict Conditions: State–Space Analysis of Multivariate EEG Synchronization

Knyazeva, M. G., Carmeli, C., Fornari, E., Meuli, R. A., SMALL, M. P., Frackowiak, R. S. J., & Maeder, P. P. (2010) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2010.21588 · Cited by 7 · see citing works

N-Acetylcysteine (NAC): Impacts on Human Health

Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. D., & Goulart, M. O. F. (2021) · Antioxidants · doi:10.3390/antiox10060967 · Cited by 526 · see citing works

Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis

Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304 · see citing works

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?

Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262 · see citing works

Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism

Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252 · see citing works

Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine

Cabungcal, J.-H., Steullet, P., Kraftsik, R., Cuenod, M., & Do, K. Q. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.020 · Cited by 232 · see citing works

Antioxidants as potential therapeutics for neuropsychiatric disorders

Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222 · see citing works

The neurobiology and treatment of first-episode schizophrenia

Kahn, R. S., & Sommer, I. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.66 · Cited by 219 · see citing works

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

Cabungcal, J.-H., Counotte, D. S., Lewis, E. M., Tejeda, H. A., Piantadosi, P., Pollock, C., Calhoon, G. G., Sullivan, E. M., Presgraves, E., Kil, J., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.028 · Cited by 204 · see citing works

Inflammation in schizophrenia: A question of balance

Leza, J. C., García‐Bueno, B., Bioque, M., Arango, C., Parellada, M., Kim, Q., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 183 · see citing works

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Conus, P., Seidman, L. J., Fournier, M., Xin, L., Cleusix, M., Baumann, P., Ferrari, C., Cousins, A., Alameda, L., Gholam‐Rezaee, M., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx093 · Cited by 163 · see citing works

Implications for reactive oxygen species in schizophrenia pathogenesis

Koga, M., Serritella, A. V., Sawa, A., & Sedlak, T. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.022 · Cited by 158 · see citing works

Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia

Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158 · see citing works

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000001 · Cited by 155 · see citing works

Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries

Davis, J., Moylan, S., Harvey, B. H., Maes, M. H. J., & Berk, M. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414533012 · Cited by 147 · see citing works

Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia

Cuénod, M., Steullet, P., Cabungcal, J.-H., Dwir, D., Khadimallah, I., Klauser, P., Conus, P., & Kim, Q. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01374-w · Cited by 129 · see citing works

T reatment and E arly I ntervention in P sychosis P rogram ( TIPP ‐ L ausanne): implementation of an early intervention programme for psychosis in S witzerland

Baumann, P. S., Crespi, S., Marion‐Veyron, R., Solida, A., Thonney, J., Favrod, J., Bonsack, C., Kim, Q., & Conus, P. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12037 · Cited by 123 · see citing works

Targeting of NMDA receptors in new treatments for schizophrenia

Hashimoto, K. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.934225 · Cited by 115 · see citing works

The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

Skvarc, D., Dean, O. M., Byrne, L. K., Gray, L. J., Lane, S. E., Lewis, M., Fernandes, B. S., Berk, M., & Marriott, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.013 · Cited by 108 · see citing works

Cognitive effects of adjunctive N-acetyl cysteine in psychosis

Rapado‐Castro, M., Dodd, S., Bush, A. I., Malhi, G. S., Skvarc, D., On, Z. X., Berk, M., & Dean, O. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716002932 · Cited by 103 · see citing works

N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence

Ooi, S. L., Green, R., & Pak, S. C. (2018) · BioMed Research International · doi:10.1155/2018/2469486 · Cited by 99 · see citing works

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Bradlow, R. C. J., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00907-3 · Cited by 87 · see citing works

Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia

Zugno, A. I., Chipindo, H. L., Volpato, A. M., Budni, J., Steckert, A. V., de Oliveira, M. B., Heylmann, A. S., Silveira, F. D. R., Mastella, G. A., Maravai, S. G., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.049 · Cited by 74 · see citing works

Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention

Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 70 · see citing works

N‐acetylcysteine as a new prominent approach for treating psychiatric disorders

Smaga, I., Frankowska, M., & Filip, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15456 · Cited by 73 · see citing works

Physical health care monitoring for people with serious mental illness

Tosh, G. E., Clifton, A., Xia, J., & White, M. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008298.pub3 · Cited by 66 · see citing works

Schizophrenia: A review of potential biomarkers

Rodrígues-Amorím, D., Baltanás, T. R., López, M., Spuch, C., Olivares, J. M., & Agís‐Balboa, R. C. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.05.009 · Cited by 62 · see citing works

N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial

Klauser, P., Xin, L., Fournier, M., Griffa, A., Cleusix, M., Jenni, R., Cuénod, M., Rolf Gruetter, A., Hagmann, P., Conus, P., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0266-8 · Cited by 57 · see citing works

Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment

De Simone, G., Mazza, B., Vellucci, L., Barone, A., Ciccarelli, M., & de Bartolomeis, A. (2023) · Antioxidants · doi:10.3390/antiox12040975 · Cited by 49 · see citing works

Drug development in schizophrenia

GOFF, D. C. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000152 · Cited by 40 · see citing works

Treatment in early psychosis with N-acetyl-cysteine for 6 months improves low-level auditory processing: Pilot study

Retsa, C., Knebel, J., Geiser, E., Ferrari, C., Jenni, R., Fournier, M., Alameda, L., Baumann, P., Clarke, S., Conus, P., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.008 · Cited by 40 · see citing works

N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study

Mullier, E., Roine, T., Griffa, A., Xin, L., Baumann, P., Klauser, P., Cleusix, M., Jenni, R., Alemán‐Gómez, Y., Rolf Gruetter, A., et al. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz022 · Cited by 38 · see citing works

Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders

Andreazza, A. C. (2012) · Molecular BioSystems · doi:10.1039/c2mb25118c · Cited by 36 · see citing works

Glutamatergic agents for schizophrenia: current evidence and perspectives

Zink, M., & Correll, C. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1040393 · Cited by 36 · see citing works

Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia

Ballesteros, A., Summerfelt, A., Du, X., Jiang, P., Chiappelli, J., Tagamets, M., O’Donnell, P., Kochunov, P., & Hong, L. E. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.05.021 · Cited by 34 · see citing works

Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia

Monte, A. S., da Silva, F. E. R., Lima, C. N. D. C., Vasconcelos, G. S., Gomes, N. S., Miyajima, F., Vasconcelos, S. M. M., Gama, C. S., Seeman, M. V., de Lucena, D. F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119875979 · Cited by 34 · see citing works

Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: A literature overview.

Schiavone, S., & Trabace, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.019 · Cited by 33 · see citing works

Connexin43 Hemichannel-Mediated Regulation of Connexin43

Li, K., Chi, Y., Gao, K., Yan, Q., Matsue, H., Takeda, M., Kitamura, M., & Yao, J. Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058057 · Cited by 29 · see citing works

Oxidative/Nitrosative Stress in Psychiatric Disorders: Are We There Yet?

O’Donnell, P., Do, K. Q., & Arango, C. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu048 · Cited by 29 · see citing works

Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia

Samuelsson, M., Skogh, E., Lundberg, K., Vrethem, M., & Öllinger, K. M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.09.014 · Cited by 27 · see citing works

Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia

GOFF, D. C. (2013) · World Psychiatry · doi:10.1002/wps.20026 · Cited by 26 · see citing works

Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation

Wang, L., Lin, P., Lee, Y., Huang, Y., Wu, C., Hsu, S., Chen, C.-C., Chong, M., Lin, C., & Hung, C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.041 · Cited by 25 · see citing works

Functional dysconnectivity in schizophrenia and its relationship to neural synchrony

Brennan, A. M., Harris, A. W. F., & Williams, L. M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811899 · Cited by 24 · see citing works

Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats

Górny, M., Wnuk, A., Kamińska, A., Kamińska, K., Chwatko, G., Bilska‐Wilkosz, A., Iciek, M., Kajta, M., Rogóż, Z., & Lorenc‐Koci, E. (2019) · Molecules · doi:10.3390/molecules24234253 · Cited by 24 · see citing works

Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia

Wu, Q., Huang, J., & Wu, R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.641047 · Cited by 24 · see citing works

N-acetyl cysteine and mushroom Agaricus sylvaticus supplementation decreased parasitaemia and pulmonary oxidative stress in a mice model of malaria

Gomes, B. A. Q., Silva, L. F. D., Gomes, A. R. Q., Moreira, D. R., Dolabela, M. F., Santos, R. S., Green, M. D., de Carvalho, E. P., & Percário, S. (2015) · Malaria Journal · doi:10.1186/s12936-015-0717-0 · Cited by 23 · see citing works

Physical health care monitoring for people with serious mental illness

Tosh, G. E., Clifton, A., Mala, S., & Bachner, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008298.pub2 · Cited by 22 · see citing works

Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats

Rao, K. N., Sentir, A. M., Engleman, E. A., Bell, R. L., Hulvershorn, L. A., Breier, A. F., & Chambers, R. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4421-8 · Cited by 19 · see citing works

Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats

Lotter, J., Möller, M., Dean, O. M., Berk, M., & Harvey, B. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00121 · Cited by 19 · see citing works

Behavioral assessment of acute inhibition of system xc - in rats

Lutgen, V., Resch, J. M., Qualmann, K. J., Raddatz, N. J., Panhans, C. M., Olander, E. M., Kong, L., Choi, S., Mantsch, J. R., & Baker, D. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3612-4 · Cited by 19 · see citing works

N-acetylcysteine prevents increased amphetamine sensitivity in social isolation-reared mice

Herrmann, A. P., Benvenutti, R., Pilz, L. K., & Elisabetsky, E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.012 · Cited by 18 · see citing works

Glutamate modulators for treatment of schizophrenia

Zhand, N., Attwood, D. G., & Harvey, P. D. (2019) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2019.02.001 · Cited by 16 · see citing works

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

Cotton, S., Berk, M., Watson, A., Wood, S. J., Allott, K., Bartholomeusz, C., Bortolasci, C. C., Walder, K. R., O'Donoghue, B. N., Dean, O. M., et al. (2019) · Trials · doi:10.1186/s13063-019-3786-5 · Cited by 16 · see citing works

Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia

Willborn, R. J., Hall, C. P., & Fuller, M. A. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.05.116 · Cited by 15 · see citing works

Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia

McQueen, G., Lay, A., Lally, J., Gabay, A. S., Collier, T., Lythgoe, D. J., Barker, G. J., Stone, J. M., McGuire, P. K., MacCabe, J. H., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05382-1 · Cited by 15 · see citing works

Ferroptosis in schizophrenia: Mechanisms and therapeutic potentials (Review)

Lv, S., & Luo, C. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13402 · Cited by 14 · see citing works

Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review

Gee, A., Dazzan, P., Grace, A. A., & Modinos, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-024-03221-2 · Cited by 12 · see citing works

A pilot case-control study on the association between N-acetyl derivatives in serum and first-episode schizophrenia

Huang, N., Cao, B., Brietzke, E. M., Park, C., Cha, D. S., Pan, Z., Zhu, J., Liu, Y., Xie, Q., Zeng, J., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.064 · Cited by 11 · see citing works

N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study

Yang, Y. S., Davis, M. C., Wynn, J. K., Hellemann, G., Green, M. F., & Marder, S. R. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.036 · Cited by 10 · see citing works

Nutrition and schizophrenia: associations worthy of continued revaluation

Tang, M., Zhao, T., Liu, T. C., Dang, R., Cai, H., & Wang, Y. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2233176 · Cited by 10 · see citing works

Oral acetylcysteine for neuropsychiatric disorders.

Racz, R., Sweet, B. V., & Sohoni, P. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140732 · Cited by 9 · see citing works

N-acetylcysteine Clinical Applications

Yahia, Z., Yahia, A., & Abdelaziz, T. (2024) · Cureus · doi:10.7759/cureus.72252 · Cited by 5 · see citing works

Preventive Effects of Ellagic Acid on Nucleus Tractus Solitarius Electrical Activity and Oxidative Stress Altered by Cerebral Global Ischemia/Reperfusion in Rat

Hoseinynejad, K., Sarkaki, A., Dianat, M., Farbood, Y., Badavi, M., & Gharib-Naseri, M. K. (2018) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2017160264 · Cited by 5 · see citing works

Novel drug treatments for schizophrenia

Coyle, J. T., & Paul, S. M. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01335-w · Cited by 5 · see citing works

Pharmacologie et mode d'action des antipsychotiques

Nicolas Franck, B., Fromager, F., & Thibaut, F. (2014) · Time to knit · doi:10.1016/s0246-1072(14)68272-9 · Cited by 4 · see citing works

Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy

Perrotta, C., Carnovale, C., Pozzi, M., Palma, C. D., Cervia, D., Nobile, M., & Clementi, E. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100061 · Cited by 2 · see citing works

Nutritional Management of Schizophrenia: Gut-Brain Axis Mechanisms and Dietary Interventions

Vakili, O., Motamed, M., Taghizadeh, M., & Khatami, S. H. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05751-w · Cited by 2 · see citing works

Traditional Plant Compounds for the Treatment of Neuropsychiatric Disorders

Din, I., Anwar, M., Rayees, S., & Malik, F. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-1761-7_18 · Cited by 2 · see citing works

The Efficacy of N-Acetyl-Cysteine (NAC) Supplementation in FST Model for Screening Antidepressants

Memudu, A. E. (2022) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2023.2356.2 · Cited by 2 · see citing works

Potential biomarkers in personality disorders: current state and future research

Piedrahíta, M. V., & Arias, J. M. C. (2016) · International journal of psychological research · doi:10.21500/20112084.2105 · Cited by 2 · see citing works

Development of novel therapy of schizophrenia in children and adolescents

Klein, C., & Bespalov, A. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.933806 · Cited by 1 · see citing works

Will the Treatment Protocols for Schizophrenia be Changing Soon?

Littrell, J. L. (2014) · Social Work in Mental Health · doi:10.1080/15332985.2014.894487 · Cited by 1 · see citing works

The Contribution of System Xc-to Prefrontal Cortical Mediated Behaviors Associated with Schizophrenia

Lutgen, V. (2012) · e-Publications@Marquette (Marquette University) · Cited by 1 · see citing works

Estrés Oxidativo y Esquizofrenia

Prados, A. B. (2014) · doi:10.14201/gredos.124073

4 – Modes d’action des antipsychotiques

Nicolas Franck, B., Fromager, F., & Thibaut, F. (2015) · doi:10.1016/b978-2-294-74633-8.00004-0

Multilevel Approaches to Schizophrenia and Other Psychotic Disorders: The Biobehavioral Interface

Walker, E. F., Ryan, A. T., Goines, K., Novacek, D. M., Goulding, S. M., Brasfield, J. L., MacDonald, A. N., & Trotman, H. D. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy322

The Role of Oxygen as a Stressor, Metabolite and Signalling Molecule and its Effect on Cell Proliferation

Franklin, E. R. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.121736

Efeito da adição de n-acetilcisteína ao tratamento com clozapina na perfusão cerebral de pacientes com esquizofrenia refratária

Souza, R. M. (2019) · doi:10.11606/d.17.2019.tde-05082019-115728

Prodromes and biological markers in schizophrenia: Importance for the dopamine, glutamate, and neurodevelopmental hypothesis

Díaz-Sánchez, J. P., Solís‐Chagoyán, H., & Benítez‐King, G. (2022) · Salud Mental · doi:10.17711/sm.0185-3325.2022.033

Alternative use of the cough drug - N-acetylcysteine in psychiatry: a review of recent clinical trials

Cieszkowska, J., Czubala, M., Czerwik, J., & Dmochowska, J. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.67.49397

New drugs for the treatment of hyperlipidemia in statin-intolerant patients - review

Płonka, W., Pelc, M., Sitarek, G., Żerek, M., Bułatowicz, M., Liber, J., Banach, K., Chruścicki, D., & Pławiak, A. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.67.49406

Glutathione Precursor, N-Acetyl-Cysteine, Modulates EEG Synchronization in Schizophrenia Patients

Carmeli, C., Maria, G. K., Cuénod, M., & Kim, Q. (2010) · IRIS · Cited by 1 · see citing works

INCREASED EEG SYNCHRONIZATION IN SCHIZOPHRENIA PATIENTS BY THE GLUTATHIONE PRECURSOR, N-ACETYL-CYSTEINE

Carmeli, C., Knyazeva, M. G., Cuénod, M., & Kim, Q. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.375

Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371 · see citing works

A glutathione precursor, N-acetyl-cysteine, modulates mismatch negativity generation in schizophrenia patients

Lavoie, S., Murray, M. M., Knyazeva, M. G., Bovet, P., Buclin, T., Conus, P., Deppen, P., Meuli, R. A., Solida, A., Cuénod, M., et al. (2007) · SERVAL (Université de Lausanne)

Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study

Girgis, R. R., Baker, S. C., Mao, X., Gil, R. B., Javitt, D. C., Kantrowitz, J. T., Gu, M., Spielman, D. M., Ojeil, N., Xu, X., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.018 · Cited by 26 · see citing works